Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)

F Panzuto, M Maccauro, D Campana, A Faggiano, S Massironi, S Pusceddu, F Spada, D Ferone, R Modica, C M Grana, P Ferolla, M Rinzivillo, G Badalamenti, M C Zatelli, F Gelsomino, E De Carlo, M Bartolomei, M P Brizzi, S Cingarlini, A VersariG Fanciulli, E Arvat, E Merola, M Cives, S Tafuto, S Baldari, M Falconi

Research output: Contribution to journalArticlepeer-review

Abstract

INTRODUCTION: The organization of the healthcare system has significantly changed after the recent COVID-19 outbreak, with a negative impact on the management of oncological patients. The present survey reports data collected by the Italian Association for Neuroendocrine Tumors on the management of patients with neuroendocrine neoplasia (NEN) during the pandemic dissemination.METHODS: A survey with 57 questions was sent to NEN-dedicated Italian centers regarding the management of patients in the period March 9, 2020, to May 9, 2020 RESULTS: The main modification in the centers' activity consisted of decreases in newly diagnosed NEN patients (- 76.8%), decreases in performed surgical procedures (- 58%), delays to starting peptide receptor radionuclide therapy (45.5%), postponed/canceled follow-up examinations (26%), and canceled multidisciplinary teams' activity (20.8%). A low proportion of centers (
Original languageEnglish
JournalJ. Endocrinol. Invest.
DOIs
Publication statusPublished - 2021

Fingerprint

Dive into the research topics of 'Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)'. Together they form a unique fingerprint.

Cite this